Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

409 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Definition of treatment goals for moderate to severe psoriasis: a European consensus.
Mrowietz U, Kragballe K, Reich K, Spuls P, Griffiths CE, Nast A, Franke J, Antoniou C, Arenberger P, Balieva F, Bylaite M, Correia O, Daudén E, Gisondi P, Iversen L, Kemény L, Lahfa M, Nijsten T, Rantanen T, Reich A, Rosenbach T, Segaert S, Smith C, Talme T, Volc-Platzer B, Yawalkar N. Mrowietz U, et al. Arch Dermatol Res. 2011 Jan;303(1):1-10. doi: 10.1007/s00403-010-1080-1. Epub 2010 Sep 21. Arch Dermatol Res. 2011. PMID: 20857129 Free PMC article.
Highly purified omega-3-polyunsaturated fatty acids for topical treatment of psoriasis. Results of a double-blind, placebo-controlled multicentre study.
Henneicke-von Zepelin HH, Mrowietz U, Färber L, Bruck-Borchers K, Schober C, Huber J, Lutz G, Kohnen R, Christophers E, Welzel D. Henneicke-von Zepelin HH, et al. Among authors: mrowietz u. Br J Dermatol. 1993 Dec;129(6):713-7. doi: 10.1111/j.1365-2133.1993.tb03338.x. Br J Dermatol. 1993. PMID: 8286257 Clinical Trial.
Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial.
Mayser P, Mrowietz U, Arenberger P, Bartak P, Buchvald J, Christophers E, Jablonska S, Salmhofer W, Schill WB, Krämer HJ, Schlotzer E, Mayer K, Seeger W, Grimminger F. Mayser P, et al. Among authors: mrowietz u. J Am Acad Dermatol. 1998 Apr;38(4):539-47. doi: 10.1016/s0190-9622(98)70114-8. J Am Acad Dermatol. 1998. PMID: 9555791 Clinical Trial.
Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial.
Gottlieb AB, Griffiths CE, Ho VC, Lahfa M, Mrowietz U, Murrell DF, Ortonne JP, Todd G, Cherill R, Marks I, Emady-Azar S, Paul CF; Multi-Centre Investigator Group. Gottlieb AB, et al. Among authors: mrowietz u. Br J Dermatol. 2005 Jun;152(6):1219-27. doi: 10.1111/j.1365-2133.2005.06661.x. Br J Dermatol. 2005. PMID: 15948985 Clinical Trial.
[The role of biologics into the management of psoriasis: a consensus paper by the Psoriasis Study Group, Arbeitsgemeinschaft Dermatologische Forschung].
Wolf-Henning B, Friedrich M, Mrowietz U, Reich K, Rosenbach T, Sticherling M, Thaçi D; Psoriasis Study Group, Arbeitsgemeinschaft Dermatologische Forschung. Wolf-Henning B, et al. Among authors: mrowietz u. J Dtsch Dermatol Ges. 2003 Aug;1(8):620-8. doi: 10.1046/j.1610-0387.2003.03014.x. J Dtsch Dermatol Ges. 2003. PMID: 16296152 German.
409 results